- Home
- GDEN vs CDNA Comparison
GDEN vs CDNA Comparison
Compare GDEN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | CDNA |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.2M | 712.2M |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GDEN | CDNA |
|---|---|---|
| Price | $27.92 | $19.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $32.20 | $26.67 |
| AVG Volume (30 Days) | 307.0K | ★ 809.8K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.20 | ★ 1.22 |
| Revenue | ★ $643,485,000.00 | $357,998,000.00 |
| Revenue This Year | N/A | $14.11 |
| Revenue Next Year | $1.97 | $12.00 |
| P/E Ratio | $136.33 | ★ $16.04 |
| Revenue Growth | N/A | ★ 14.46 |
| 52 Week Low | $19.57 | $10.96 |
| 52 Week High | $35.49 | $25.95 |
Technical Indicators
Market Signals| Indicator | GDEN | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 58.13 |
| Support Level | $27.72 | $19.21 |
| Resistance Level | $28.70 | $20.92 |
| Average True Range (ATR) | 0.55 | 0.91 |
| MACD | -0.28 | -0.04 |
| Stochastic Oscillator | 4.35 | 53.54 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.